Fresenius Medical Care AG & Co. KGaA (ETR:FME) Receives €64.00 Price Target at Jefferies Financial Group

0

Fresenius Medical Care AG & Co. KGaA (ETR: FMEGet a rating) was given a price target of €64.00 ($67.37) by analysts at Jefferies Financial Group in a report on Monday, Borsen Zeitung reports. Jefferies Financial Group’s target price would indicate a potential upside of 35.91% from the current share price.

Other equity research analysts have also published reports on the company. Barclays set a price target of €68.00 ($71.58) on Fresenius Medical Care AG & Co. KGaA in a research report on Wednesday, June 22. Deutsche Bank Rese… set a price target of €58.00 ($61.05) on Fresenius Medical Care AG & Co. KGaA in a Thursday, May 5 research report. Warburg Research set a price target of €62.00 ($65.26) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, May 10 report. Deutsche Bank Aktiengesellschaft set a price target of €58.00 ($61.05) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, March 22 report. Finally, UBS Group set a €75.00 ($78.95) price target on Fresenius Medical Care AG & Co. KGaA in a Wednesday, June 22 report.

Shares of ETR FME open at €47.09 ($49.57) on Monday. Fresenius Medical Care AG & Co. KGaA has a one-year minimum of €43.53 ($45.82) and a one-year maximum of €71.14 ($74.88). The company has a market capitalization of $13.80 billion and a PE ratio of 15.72. The company has a current ratio of 1.26, a quick ratio of 0.79 and a debt ratio of 91.78. The company has a 50-day moving average price of €55.93 and a two-hundred-day moving average price of €57.43.

About Fresenius Medical Care AG & Co. KGaA (Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Read more



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.